1. Variations in Training of Surgical Oncologists: Proposal for a Global Curriculum

   • C. Are
   • A. Caniglia
   • L. Wyld

   Healthcare Policy and Outcomes 27 April 2016 Pages: 1769 - 1781

   

2. Global Curriculum in Surgical Oncology

   • Chandrakanth Are
   • R. S. Berman
   • R. A. Audisio

   Healthcare Policy and Outcomes 27 April 2016 Pages: 1782 - 1795

   

3. Intraoperative Radiation Therapy in Breast Cancer: Still Not Ready for Prime Time

   • Chirag Shah
   • Jessica Wobb
   • Atif Khan

   Breast Oncology 22 February 2016 Pages: 1796 - 1798

4. The Search Continues for the Ideal Method to Localize Nonpalpable Breast Lesions

   • James W. Jakub

   Breast Oncology 23 February 2016 Pages: 1799 - 1800

5. What are We Going to Do with Complete Responses After Chemoradiation of Rectal Cancer?

   • Geerard L. Beets

   Colorectal Cancer 08 March 2016 Pages: 1801 - 1802

6. Factors Associated with Short-Term Mortality After Surgical Oncologic Emergencies

   • Marianne R. F. Bosscher
   • Esther Bastiaannet
   • Harald J. Hoekstra

   Healthcare Policy and Outcomes Open access 09 November 2015 Pages: 1803 - 1814

   

7. Primary Tumor Resection and Multimodality Treatment for Patients with Metastatic Colon Cancer

   • Nader N. Massarweh
   • Linda T. Li
   • Daniel A. Anaya

   Healthcare Policy and Outcomes 19 January 2016 Pages: 1815 - 1823

   

8. Pilot Study of a New Nonradioactive Surgical Guidance Technology for Locating Nonpalpable Breast Lesions

   • Charles E. Cox
   • Norbert Garcia-Henriquez
   • Steven C. Shivers

   Breast Oncology 03 February 2016 Pages: 1824 - 1830

   

9. Do Patients After Reexcision Due to Involved or Close Margins Have the Same Risk of Local Recurrence as Those After One-Step Breast-Conserving Surgery?

   • André Hennigs
   • Valerie Fuchs
   • Joerg Heil

   Gynecologic Oncology 05 January 2016 Pages: 1831 - 1837

   

10. Optimal Surgical Management for Occult Breast Carcinoma: A Meta-analysis

    • Francisco Igor B. Macedo
    • Joseph J. Eid
    • Vijay K. Mittal

    Breast Oncology 01 February 2016 Pages: 1838 - 1844

    

11. Using Multilevel Models to Explain Variation in Clinical Practice: Surgeon Volume and the Surgical Treatment of Breast Cancer

    • Stacey Fisher
    • Yutaka Yasui
    • Marcy Winget

    Breast Oncology 02 February 2016 Pages: 1845 - 1851

    

12. Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort Analysis

    • Francesca De Lorenzi
    • Pietro Loschi
    • Rietjens Mario

    Breast Oncology 02 February 2016 Pages: 1852 - 1859

    

13. Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation?

    • Soo-Yeon Kim
    • Eun-Kyung Kim
    • Hee Jung Moon

    Breast Oncology 26 February 2016 Pages: 1860 - 1866

    

14. Comparison of Long-Term Outcomes Between Emergency Surgery and Bridge to Surgery for Malignant Obstruction in Right-Sided Colon Cancer: A Multicenter Retrospective Study

    • Bong-Hyeon Kye
    • Yoon Suk Lee
    • Hyung-Jin Kim

    Colorectal Cancer 26 January 2016 Pages: 1867 - 1874

    

15. Colorectal Cancer Resections in the Oldest Old Between 2011 and 2012 in The Netherlands

    • N. M. Verweij
    • A. H. W. Schiphorst
    • M. E. Hamaker

    Colorectal Cancer 19 January 2016 Pages: 1875 - 1882

    

16. Local Recurrence in the Lateral Lymph Node Compartment: Improved Outcomes with Induction Chemotherapy Combined with Multimodality Treatment

    • Miranda Kusters
    • Sietske J. Bosman
    • Harm J. T. Rutten

    Colorectal Cancer 02 February 2016 Pages: 1883 - 1889

    

17. KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion

    • Junichi Shindoh
    • Yujiro Nishioka
    • Norihiro Kokudo

    Colorectal Cancer 19 January 2016 Pages: 1890 - 1896

    

18. Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases

    • Isamu Hosokawa
    • Marc-Antoine Allard
    • René Adam

    Hepatobiliary Tumors 28 January 2016 Pages: 1897 - 1905

    

19. Percutaneous Treatment of Localized Infiltrative Hepatocellular Carcinoma Developing on Cirrhosis

    • Jean-Charles Nault
    • Gisèle Nkontchou
    • Olivier Seror

    Hepatobiliary Tumors 05 January 2016 Pages: 1906 - 1915

    

20. CD133 Expression at the Metastatic Site Predicts Patients’ Outcome in Colorectal Cancer with Synchronous Liver Metastasis

    • Junko Kishikawa
    • Shinsuke Kazama
    • Toshiaki Watanabe

    Hepatobiliary Tumors 29 January 2016 Pages: 1916 - 1923

    

21. Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01)

    • Bernd Kasper
    • Viktor Gruenwald
    • Florian Haller

    Bone and Soft Tissue Sarcomas 09 February 2016 Pages: 1924 - 1927

    

22. The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

    • Vladimir Milovanov
    • Armando Sardi
    • Vadim Gushchin

    Gastrointestinal Oncology 29 December 2015 Pages: 1928 - 1933

    

23. Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer

    • Mitsuro Kanda
    • Akira Mizuno
    • Yasuhiro Kodera

    Gastrointestinal Oncology 03 February 2016 Pages: 1934 - 1940

    

24. Factors Associated with Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis

    • Alexander S. Martin
    • Daniel E. Abbott
    • Syed A. Ahmad

    Gastrointestinal Oncology 02 February 2016 Pages: 1941 - 1947

    

25. Frequency of Resection After Preoperative Chemotherapy or Chemoradiotherapy for Gastric Adenocarcinoma

    • Brian Badgwell
    • Mariela Blum
    • Jaffer Ajani

    Gastrointestinal Oncology 11 February 2016 Pages: 1948 - 1955

    

26. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy

    • Haejin In
    • Olga Kantor
    • Mitchell C. Posner

    Gastrointestinal Oncology 11 January 2016 Pages: 1956 - 1962

    

27. Risk Factors for the Loss of Lean Body Mass After Gastrectomy for Gastric Cancer

    • Toru Aoyama
    • Tsutomu Sato
    • Takaki Yoshikawa

    Gastrointestinal Oncology 13 January 2016 Pages: 1963 - 1970

    

28. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?

    • C. S. Chia
    • B. You
    • the BIG RENAPE Group

    Gastrointestinal Oncology 11 January 2016 Pages: 1971 - 1979

    

29. Splenectomy Increases Postoperative Complications Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    • Francois Dagbert
    • Remy Thievenaz
    • Olivier Glehen

    Gastrointestinal Oncology 25 February 2016 Pages: 1980 - 1985

    

30. Effect of EGFR and p-AKT Overexpression on Chromosomal Instability in Gastric Cancer

    • Yuichi Hisamatsu
    • Eiji Oki
    • Yoshihiko Maehara

    Gastrointestinal Oncology 04 February 2016 Pages: 1986 - 1992

    

31. Adjuvant Trametinib Delays the Outgrowth of Occult Pancreatic Cancer in a Mouse Model of Patient-Derived Liver Metastasis

    • Timothy E. Newhook
    • James M. Lindberg
    • Todd W. Bauer

    Pancreatic Tumors 04 February 2016 Pages: 1993 - 2000

    

32. Laparoscopic Insulinoma Enucleation from the Retro-Pancreatic Neck: A Stepwise Approach

    • Claudius Conrad
    • Guillaume Passot
    • Jeffrey E. Lee

    Original Article – Pancreatic Tumors 09 March 2016 Pages: 2001 - 2001

33. Elderly Patients Strongly Benefit from Centralization of Pancreatic Cancer Surgery: A Population-Based Study

    • Lydia G. M. van der Geest
    • Marc G. H. Besselink
    • Valery E. P. P. Lemmens

    Pancreatic Tumors 21 January 2016 Pages: 2002 - 2009

    

34. Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2–≤4, pT3: >4 cm) is More Valid and Clinically Relevant

    • Burcu Saka
    • Serdar Balci
    • Volkan Adsay

    Pancreatic Tumors 29 January 2016 Pages: 2010 - 2018

    

35. Prognostic Impact of Para-Aortic Lymph Node Micrometastasis in Pancreatic Ductal Adenocarcinoma

    • Toshiaki Komo
    • Yoshiaki Murakami
    • Taijiro Sueda

    Pancreatic Tumors 08 February 2016 Pages: 2019 - 2027

    

36. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients

    • Giovanni Ramacciato
    • Giuseppe Nigri
    • Ugo Boggi

    Pancreatic Tumors 18 February 2016 Pages: 2028 - 2037

    

37. Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients

    • Kuninori Otsuka
    • Yorihisa Imanishi
    • Toshitaka Nagao

    Head and Neck Oncology Open access 20 January 2016 Pages: 2038 - 2045

    

38. The Dual Inhibition of Met and EGFR by ME22S, a Novel Met/EGFR Bispecific Monoclonal Antibody, Suppresses the Proliferation and Invasion of Laryngeal Cancer

    • Bok-Soon Lee
    • Haeng-Jun Kim
    • Chul-Ho Kim

    Head and Neck Oncology 26 January 2016 Pages: 2046 - 2053

    

39. Comparison of Oncological and Functional Outcomes between Initial Surgical versus Non-Surgical Treatments for Hypopharyngeal Cancer

    • Jeon Yeob Jang
    • Eun-Hye Kim
    • Han-Sin Jeong

    Head and Neck Oncology 19 January 2016 Pages: 2054 - 2061

    

40. Health-Related Quality of Life for Patients Who have In-Transit Melanoma Metastases Treated with Isolated Limb Perfusion

    • Ann-Sophie Lindqvist Bagge
    • Ilan Ben-Shabat
    • Roger Olofsson Bagge

    Melanomas 11 February 2016 Pages: 2062 - 2069

    

41. Magnetic Technique for Sentinel Lymph Node Biopsy in Melanoma: The MELAMAG Trial

    • Bauke Anninga
    • Samantha H. White
    • MELAMAG Multicentre Trialists Group

    Melanomas 19 February 2016 Pages: 2070 - 2078

42. Blood Loss and Transfusion Requirements in Metastatic Spinal Tumor Surgery: Evaluation of Influencing Factors

    • Naresh Kumar
    • Aye Sandar Zaw
    • Raymond Goy

    Neuro-Oncology 27 January 2016 Pages: 2079 - 2086

43. Solitary Lymph Node Recurrence of Esophageal Squamous Cell Carcinoma: Surgical Failure or Systemic Disease?

    • Tomoki Makino
    • Makoto Yamasaki
    • Yuichiro Doki

    Thoracic Oncology 13 January 2016 Pages: 2087 - 2093

    

44. A Population-Based Cost Analysis of Thoracoscopic Versus Open Lobectomy in Primary Lung Cancer

    • Bing-Yen Wang
    • Jing-Yang Huang
    • Yung-Po Liaw

    Thoracic Oncology Open access 04 February 2016 Pages: 2094 - 2098

45. Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis

    • Yue Zhao
    • Rui Wang
    • Haiquan Chen

    Thoracic Oncology Open access 02 February 2016 Pages: 2099 - 2105

    

46. Postoperative Infectious Complications are Associated with Adverse Oncologic Outcomes in Esophageal Cancer Patients Undergoing Preoperative Chemotherapy

    • Kotaro Yamashita
    • Tomoki Makino
    • Yuichiro Doki

    Thoracic Oncology 11 January 2016 Pages: 2106 - 2114

    

47. Epidermal Growth Factor Receptor Mutation Status and Treatment Outcome for R0-Resected Patients with Stage 3 Non-small Cell Lung Cancer

    • Song Ran Liu
    • Bo Qiu
    • Hui Liu

    Thoracic Oncology 17 February 2016 Pages: 2115 - 2122